According to Dechra Pharmaceuticals's latest financial reports the company has S$0.12 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-06-30 | S$0.12 B | -37.69% |
2022-06-30 | S$0.20 B | -7.32% |
2021-06-30 | S$0.22 B | -43.5% |
2020-06-30 | S$0.39 B | 182.85% |
2019-06-30 | S$0.13 B | -3.88% |
2018-06-30 | S$0.14 B | 30.71% |
2017-06-30 | S$0.10 B | 54.14% |
2016-06-30 | S$71.2 M | -27.77% |
2015-06-30 | S$98.58 M | 72.98% |
2014-06-30 | S$56.99 M | -9.79% |
2013-06-30 | S$63.17 M | -1.97% |
2012-06-30 | S$64.45 M | 6.62% |
2011-06-30 | S$60.44 M | -8.24% |
2010-06-30 | S$65.87 M | 3.06% |
2009-06-30 | S$63.92 M | 6.23% |
2008-06-30 | S$60.17 M | 12.88% |
2007-06-30 | S$53.3 M | -7.69% |
2006-06-30 | S$57.74 M | 37.48% |
2005-06-30 | S$42 M | |
2001-06-30 | S$9.19 M | -54.39% |
2000-06-30 | S$20.16 M | 99.53% |
1999-06-30 | S$10.1 M | 14.28% |
1998-06-30 | S$8.84 M |